SAN

86.11

-0.15%↓

MRK1

115.55

-0.43%↓

ARGX

788.4

-0.2%↓

PHIA

24.15

-0.66%↓

ONC.US

340.64

+1.61%↑

SAN

86.11

-0.15%↓

MRK1

115.55

-0.43%↓

ARGX

788.4

-0.2%↓

PHIA

24.15

-0.66%↓

ONC.US

340.64

+1.61%↑

SAN

86.11

-0.15%↓

MRK1

115.55

-0.43%↓

ARGX

788.4

-0.2%↓

PHIA

24.15

-0.66%↓

ONC.US

340.64

+1.61%↑

SAN

86.11

-0.15%↓

MRK1

115.55

-0.43%↓

ARGX

788.4

-0.2%↓

PHIA

24.15

-0.66%↓

ONC.US

340.64

+1.61%↑

SAN

86.11

-0.15%↓

MRK1

115.55

-0.43%↓

ARGX

788.4

-0.2%↓

PHIA

24.15

-0.66%↓

ONC.US

340.64

+1.61%↑

Search

Vetoquinol SA

Deschisă

SectorSănătate

72.1 -0.41

Rezumat

Modificarea prețului

24h

Curent

Minim

70.9

Maxim

72.5

Indicatori cheie

By Trading Economics

Venit

-9.8M

25M

Vânzări

-17M

258M

P/E

Medie Sector

14.177

79.874

Randament dividend

1.26

Marjă de profit

9.734

Angajați

2,497

EBITDA

-12M

48M

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.26%

2.31%

Statistici piață

By TradingEconomics

Capitalizare de piață

-54M

855M

Deschiderea anterioară

72.51

Închiderea anterioară

72.1

Sentimentul știrilor

By Acuity

50%

50%

168 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Vetoquinol SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 nov. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27 nov. 2025, 15:32 UTC

Achiziții, Fuziuni, Preluări

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27 nov. 2025, 23:50 UTC

Market Talk

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27 nov. 2025, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 nov. 2025, 16:05 UTC

Market Talk

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27 nov. 2025, 16:04 UTC

Market Talk

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27 nov. 2025, 15:54 UTC

Achiziții, Fuziuni, Preluări

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27 nov. 2025, 15:44 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27 nov. 2025, 15:43 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27 nov. 2025, 15:42 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27 nov. 2025, 15:41 UTC

Achiziții, Fuziuni, Preluări

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27 nov. 2025, 15:11 UTC

Market Talk

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27 nov. 2025, 14:26 UTC

Market Talk

Hermes' Outperformance Gap Could Narrow -- Market Talk

27 nov. 2025, 14:11 UTC

Market Talk

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27 nov. 2025, 14:11 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

27 nov. 2025, 13:35 UTC

Market Talk

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27 nov. 2025, 13:33 UTC

Market Talk

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27 nov. 2025, 13:22 UTC

Market Talk

Global Equities Roundup: Market Talk

27 nov. 2025, 13:22 UTC

Market Talk

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27 nov. 2025, 13:17 UTC

Market Talk

LVMH Should Be Able to Recover Next Year -- Market Talk

27 nov. 2025, 11:13 UTC

Market Talk

European Gas Prices Come Under Pressure -- Market Talk

27 nov. 2025, 11:07 UTC

Câștiguri

Genting: Positive About Prospects Over Longer Term

27 nov. 2025, 11:06 UTC

Câștiguri

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27 nov. 2025, 11:04 UTC

Câștiguri

Genting: International Travel Demand Expected to Remain Resilient

27 nov. 2025, 11:04 UTC

Câștiguri

Genting: Global Growth Expected to Remain Subdued

27 nov. 2025, 11:04 UTC

Câștiguri

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27 nov. 2025, 10:59 UTC

Câștiguri

Genting Bhd 3Q Net Profit Fell 86% on Year

27 nov. 2025, 10:58 UTC

Câștiguri

Genting Bhd 3Q Rev Rose 14% on Year

27 nov. 2025, 10:56 UTC

Câștiguri

Genting Bhd 3Q Net MYR30.3M

27 nov. 2025, 10:56 UTC

Câștiguri

Genting Bhd 3Q EPS MYR0.0079

Comparație

Modificare preț

Vetoquinol SA Așteptări

Consens privind evaluarea

By TipRanks

0 ratings

0

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

72.6 / 75.1Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

168 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat